Diflunisal (Dolobid)
Nonsteroidal Anti-inflammatory Drug class · 3 generic manufacturers · 5 ANDAs filed at FDA.
$8.0M in CY2024 Part D spend16K claims · 6K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Diflunisal used for?
Diflunisal is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Diflunisal?
Yes. 5 ANDAs filed at FDA, 3 generic manufacturers currently shipping.
How much does my plan pay for Diflunisal?
Across 329 Part D plans, Diflunisal averages $1.06/unit (NADAC). Lowest available: $1.06/unit. Highest in distribution: $1.06/unit.
Is Diflunisal on the FDA shortage list?
No. Diflunisal is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (5 approvals on file) · NADAC unit costs: CMS NADAC weekly file (6 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.